SmartSkin Technologies announced Martin VanTrieste has joined its board of directors to offer his unique insights on how to maximize pharmaceutical manufacturing capacity and the executive-level considerations that go into those decisions.
An accomplished entrepreneur, board governance expert, executive coach, and biopharmaceutical executive, Van Trieste is highly respected around the world for his accomplishments and ability to effect change quickly. He held various positions in the pharmaceutical industry for more than 20 years and founded CivicaRX in retirement. He now serves as president emeritus. VanTrieste’s comprehensive knowledge and experience in pharmaceutical manufacturing, quality systems, and government regulations will add insights to SmartSkin’s expansion plans.
“Martin is well-known in the pharmaceutical industry. His experience with quality, operations, and leadership will provide us with the insights we’re looking for to accelerate our growth. We were first introduced to him by Schott, and I was impressed with how he looks at what’s possible and how to quickly build a plan and take action,” says SmartSkin CEO Evan Justason. “We are excited to have him join our board. He has already provided invaluable insight on how we can position SmartSkin and made some important introductions.”
“The pharmaceutical industry is ripe for change. SmartSkin’s technology is helping manufacturers increase production, improve quality, and reduce waste. I believe their expertise and hardware/software solutions are the future of pharmaceutical manufacturing, and I want to help make that possible,” says VanTrieste.
SmartSkin technology helps the industry adapt faster and improve production quality by providing timely data from the container’s perspective inside the production process, from the washer to warehousing.
